| Multidrug‐resistant, extensively drug‐resistant and pandrug‐resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance AP Magiorakos, A Srinivasan, RB Carey, Y Carmeli, ME Falagas, ... Clinical microbiology and infection 18 (3), 268-281, 2012 | 5067 | 2012 |
| Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses ME Falagas, EI Pitsouni, GA Malietzis, G Pappas The FASEB journal 22 (2), 338-342, 2008 | 1688 | 2008 |
| Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections ME Falagas, SK Kasiakou, LD Saravolatz Clinical infectious diseases 40 (9), 1333-1341, 2005 | 1358 | 2005 |
| Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis G Pappas, N Roussos, ME Falagas International journal for parasitology 39 (12), 1385-1394, 2009 | 728 | 2009 |
| Toxicity of polymyxins: a systematic review of the evidence from old and recent studies ME Falagas, SK Kasiakou Critical care 10 (1), R27, 2006 | 655 | 2006 |
| Obesity and infection ME Falagas, M Kompoti The Lancet infectious diseases 6 (7), 438-446, 2006 | 632 | 2006 |
| Current control and treatment of multidrug-resistant Acinetobacter baumannii infections DE Karageorgopoulos, ME Falagas The Lancet infectious diseases 8 (12), 751-762, 2008 | 587 | 2008 |
| Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review PI Rafailidis, EG Mourtzoukou, IC Varbobitis, ME Falagas Virology journal 5 (1), 47, 2008 | 507 | 2008 |
| Extended-spectrum β-lactamase-producing organisms ME Falagas, DE Karageorgopoulos Journal of Hospital infection 73 (4), 345-354, 2009 | 504 | 2009 |
| The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa ME Falagas, PK Koletsi, IA Bliziotis Journal of medical microbiology 55 (12), 1619-1629, 2006 | 488 | 2006 |
| β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis DE Karageorgopoulos, EK Vouloumanou, F Ntziora, A Michalopoulos, ... Clinical Infectious Diseases 52 (6), 750-770, 2011 | 458 | 2011 |
| Comparison of SCImago journal rank indicator with journal impact factor ME Falagas, VD Kouranos, R Arencibia-Jorge, DE Karageorgopoulos The FASEB journal 22 (8), 2623-2628, 2008 | 452 | 2008 |
| Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review ME Falagas, AC Kastoris, AM Kapaskelis, DE Karageorgopoulos The Lancet infectious diseases 10 (1), 43-50, 2010 | 442 | 2010 |
| Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? ME Falagas, IA Bliziotis International journal of antimicrobial agents 29 (6), 630-636, 2007 | 438 | 2007 |
| Epidemiology of constipation in Europe and Oceania: a systematic review G Peppas, VG Alexiou, E Mourtzoukou, ME Falagas BMC gastroenterology 8 (1), 5, 2008 | 403 | 2008 |
| Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature ME Falagas, P Kopterides Journal of Hospital Infection 64 (1), 7-15, 2006 | 358 | 2006 |
| Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations J Ariza, M Bosilkovski, A Cascio, JD Colmenero, MJ Corbel, ME Falagas, ... PLoS medicine 4 (12), e317, 2007 | 335 | 2007 |
| Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic AS Michalopoulos, S Tsiodras, K Rellos, S Mentzelopoulos, ME Falagas Clinical microbiology and infection 11 (2), 115-121, 2005 | 332 | 2005 |
| Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology ME Falagas, DE Karageorgopoulos Clinical infectious diseases 46 (7), 1121-1122, 2008 | 314 | 2008 |
| Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies ME Falagas, IA Bliziotis, II Siempos Critical care 10 (2), R48, 2006 | 313 | 2006 |
Drosos E. Karageorgopoulos, MD, Ph...Alfa Institute of Biomedical Sciences (AIBS), Athens, GreeceVerified email at aibs.gr
